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Peter J. Pappas, MD,c Baltimore, Md; and Newark, NJ
Objectives: Cognitive function has not been evaluated systematically in the context of carotid endarterectomy (CEA)
versus carotid artery stenting (CAS). Cognitive decline can occur from microembolization or hypoperfusion during CEA
or CAS. Carotid revascularization may, however, also improve cognitive dysfunction resulting from chronic hypoperfu-
sion. We compared cognitive outcomes in consecutive asymptomatic patients undergoing CAS or CEA.
Methods: This is a prospective nonrandomized single-center study of patients with asymptomatic carotid stenosis >70%
undergoing CAS or CEA using standard techniques. Neurologic symptoms were evaluated by history, physical
examination, and the National Institutes of Health Stroke Scale. A 50-minute cognitive battery was performed 1 to 3 days
before and 4 to 6 months after CEA/CAS. The tests (Trail Making Tests A/B, Processing Speed Index (PSI) of the
Wechsler Adult Intelligence Scale – Third Edition (WAIS-III), Boston Naming Test, Working Memory Index (WMI) of
the Wechsler Memory Scale  Third Edition (WMS-III), Controlled Oral Word Association, and Hopkins Verbal
Learning Test) for six cognitive domains (motor speed/coordination and executive function, psychomotor speed,
language (naming), working memory/concentration, verbal fluency, and learning/memory) were conducted by a
neuropsychologist. The primary analysis of impact of treatment modality was a normalized cognitive change score.
Results: Forty-six patients underwent prepost testing (CEA 25, CAS 21). Women comprised 36% of the cohort, mean
preprocedural stenosis was 84%, and 54% were right-sided lesions. All patients were successfully revascularized without
periprocedural complications. The scores for each test improved after CEA except WMI, which decreased in 20 of 25
patients. Improvement occurred in all tests after CAS except PSI, which decreased in 18 of 21 patients. In addition to
comparing the changes in individual test scores, overall cognitive change was measured by calculating the change in
composite cognitive score (CCS) postprocedure versus baseline. To compute the CCS, the raw scores from each test were
transformed into z scores and then averaged to calculate each patient’s composite score. The composite score at baseline
was then compared with that from the postprocedure testing. The CCS improved after both CEA and CAS, and the
changes were not significantly different between the groups (.51 vs .47; P  NS).
Conclusions: Carotid revascularization results in an overall improvement in cognitive function. There are no differences in
the composite scores of five major cognitive domains between CEA and CAS. When individual tests are compared, CEA
results in a reduction in memory, while CAS patients show reduced psychomotor speed. Larger studies will help confirm
these findings. ( J Vasc Surg 2011;54:691-8.)
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tCognitive function is being increasingly recognized as
an important outcome measure that affects patient well-
being, functional status, and quality of life.1-3 Almost 30%
of patients may experience cognitive impairment after car-
diac surgery.4 This has stimulated extensive research to
establish standards of prevention,5 management,5 testing,6
and reporting7 of cognitive impairment after cardiac sur-
gery. However, cognitive function has not been evaluated
systematically in the context of carotid revascularization.
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doi:10.1016/j.jvs.2011.03.253linical investigations designed to contrast the efficacy of
arotid endarterectomy (CEA) versus best medical therapy,
nd CEA versus carotid artery stenting (CAS) in patients
ith carotid artery stenosis have only been based on the
raditional end points of stroke, myocardial infarction
MI), and death.
A decline in cognitive function could occur during
arotid revascularization from microembolic ischemia dur-
ng surgical dissection (CEA) or intravascular instrumenta-
ion (CAS). It could also occur from hypoperfusion during
lamping (CEA) or balloon dilation (CAS). Conversely,
estoring perfusionmay improve cognitive dysfunction that
ay have occurred from a state of chronic hypoperfusion. It
s not known whether these complex interactions ultimately
esult in a net improvement or deterioration of cognitive
unction. Furthermore, it is not known whether the two
ethods of carotid revascularization have a differential effect
n cognitive outcome. It is well-known though, that there is a
ositive relationship between improvement in cognition and
mprovement in functional outcome of patients.1,3
The reviews of Lunn et al8 and Irvine et al9 exemplify
he current absence of consensus regarding cognitive out-
ome after CEA. They found that 16 of 28 studies demon-
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12 studies showed no improvement or a decline.
Ghogawala et al identified 17 additional studies that pro-
vided follow-up cognitive data for at least 1 month after
carotid revascularization and found equally conflicting re-
sults. There are even fewer studies addressing cognitive
outcome after CAS,10-14 and they have variously reported a
decline, improvement, or no change in cognitive function
after the procedure. These conflicting results may, in part,
be explained by the sample sizes, short duration of follow-
up, variability in the timing of cognitive assessment, the
types of cognitive tests used, types of cognitive domains
tested, use of comparators, absence of baseline assessments,
and significant variability of severity of stenosis or pre-
existing neurological symptoms in patients.
Only two studies have compared cognitive outcomes
between surgical and endovascular carotid revasculariza-
tion.10,11 However, they used limited cognitive testing on
a mixed cohort of symptomatic and asymptomatic patients,
and a significant proportion of patients underwent angio-
plasty without stenting in the endovascular arm of the
cohort. One other study compared stenting to CEA but
used a limited cognitive evaluation restricted to left-
hemispheric functions alone (the Mini Mental State Exam-
ination) and did not find any differences.12 No formal
assessment of cognitive function has been made in prior or
recent randomized trials comparing revascularization strat-
egies for carotid stenosis.15-18 There is a strong need for
such an evaluation to test whether carotid revascularization
does indeed have an effect beyond prevention of stroke.
Furthermore, since the major North American carotid trial
failed to show a difference in combined stroke, MI and
death rate between CAS and CEA,17 the superiority of a
procedure may be predicated on cognitive outcome.
In this study, we developed, implemented, and evalu-
ated a unique battery of cognitive tests designed specifically
for patients with carotid stenosis. The battery was imple-
mented in patients with asymptomatic high-grade carotid
stenosis undergoing revascularization (CEA or CAS) at
baseline and 4 to 6 months postprocedure. A standard-
ized change score of the average of all the tests at baseline
versus postprocedure testing served as the primary anal-
ysis of impact on cognition. A secondary analysis com-
pared change scores for separate cognitive domains eval-
uated by individual tests.
METHODS
Patients and study design. This was a prospective
nonrandomized single-center study of patients with asymp-
tomatic primary carotid stenosis70% undergoing CAS or
CEA using standard techniques. Patients were recruited at
SaintMichael’sMedical Center. Since stroke is known to be
associated with cognitive impairment, and since stroke may
interfere with the performance of certain cognitive tests
even in the absence of a cognitive deficit, we did not recruit
symptomatic patients in this study.19 Only patients without
neurological symptoms of a stroke, transient ischemic at-
tack or amaurosis fugax were considered for the study.atients with medical conditions limiting life expectancy
1 year) or interfering with outcome evaluations were
xcluded. Duplex ultrasonography was utilized to assess the
egree of carotid stenosis using modified Washington Uni-
ersity velocity criteria published and validated by our
roup previously.20 Neurologic assessment involved a his-
ory, physical examination, and the National Institutes of
ealth Stroke Scale21 implemented by a qualified vascular
urgeon. Patients were evaluated at baseline within 1 to 3
ays prior to their revascularization procedure and again at
to 6 months after revascularization.
Carotid revascularization procedures. All physicians
ere fellowship trained in Vascular and Endovascular Sur-
ery. The Division’s protocol for CEA is standardized for
eneral anesthesia, surgical incision, intraoperative moni-
oring, the use of a shunt, and patch angioplasty.22 The
rotocol for CAS is also standardized, including local anes-
hesia, periprocedural monitoring, use of an embolic pro-
ection device, mandatory stenting, and the use of antico-
gulation and antiplatelet agents.20 The selection of the
ype of revascularization (CEA or CAS) to be utilized in
ach patient was according to patient/surgeon preference
nd was not influenced by the study.
Cognitive testing protocol. The National Institute of
eurological Disorders-Canadian Stroke Network (NINDS-
SN) harmonization standards for testing vascular cogni-
ive impairment,23 previous experience from the assess-
ent of cognitive function in cardiac surgery,7,24
edical treatment outcomes studies,25 and carotid re-
ascularization studies8-14 were utilized to select the test
attery. These reports emphasize testing within specific
ognitive domains with an analysis of both composite
nd domain-specific outcomes.26 They also recommend
ollow-up testing remote from the intervention to avoid
onfounding the results with periprocedural medications
nd/or stress.
A 50-minute cognitive battery was performed 1 to 3
ays before and 4 to 6 months after CEA/CAS. The tests27
or six cognitive domains (motor speed/coordination and
xecutive function, psychomotor speed, language [nam-
ng], working memory/concentration, verbal fluency, and
earning/memory) were conducted by a neuropsycholo-
ist. We selected tests that were broadly accepted cognitive
easures with standardized administration procedures and
ell-documented validity, accuracy, and reliability statis-
ics.27 All patients underwent all cognitive tests. The
rder of test administration was constant for baseline and
ollow-up evaluations. Tests were conducted in a quiet
oom. The order of administration accommodated the
elays required for recall intervals and minimized stimuli
nterference in memory tasks.
Cognitive testing battery.
. Trail Making Test (TMT)28 is a two-part test of motor
speed/coordination and executive function. The first
part, Trails A, requires the subject to draw lines to connect
numbered circles, in consecutive order, that are randomly
arranged on a page. In Trails B, the subject connects
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Volume 54, Number 3 Lal et al 693randomly arranged, numbered and lettered circles by alter-
nating between them (1, A, 2, B, 3, C, etc.). The test is
timed and the subject is urged to connect the circles “as fast
as you can” without lifting the pencil from the paper. The
score for each test is the total time to completion.
2. Processing Speed Index is a subset of the Wechsler
Adult Intelligence Scale-Third Edition (WAIS-III)29
and can measure psychomotor speed. Digit Symbol
Coding requires the patient to quickly match and copy a
series of symbols to a series of numbers. Symbol Search
requires the patient to assess a series of stimuli to deter-
mine if a given target is present. Both of these tests
require the patient to do as many items as possible in 2
minutes. The number of items completed is the score.
3. Boston Naming Test30 is a language task used to assess
the ability to name pictured objects. It consists of 60
line-drawn objects of graded difficulty ranging from
“bed” to “abacus.” The pictures are presented one at a
time on cards, and two prompting cues can be given if
the subject does not produce the word spontaneously.
The score is the total number of correct words given
without a phonemic cue.
4. Working Memory Index is part of the Wechsler Mem-
ory Scale-Third Edition (WMS-III)31 composed of the
Letter-Numbering Sequencing and the Spatial Span
tests to assess working memory/concentration. The
Letter-Number sequencing test requires the patient to
repeat back a series of random numbers and letters in
ascending order (numbers) and alphabetical order. The
task gets increasingly difficult as more numbers and
letters are added. Spatial Span requires the subject to
point to a series of blocks in an array in the same order
that the examiner does and later in the reverse order
from the examiner.
5. Controlled Oral Word Association Test (COWA)32
assesses verbal fluency in three word-naming trials. Each
1-minute trial requires the production of words begin-
ning with a given letter (F, A, S; excluding proper names
and the same word with a different suffix) with the test
score equaling the sum of all acceptable words.
6. Hopkins Verbal Learning Test (HVLT-revised)33 is
a word-list learning task used to assess a subject’s ability
to recall a list of words after a delay. Over three trials, a
12-word list of three semantic categories is presented to
the subject who then recalls as many words as possible,
in any order. After a 20-minute delay, a recall trial is
administered. The score is the total number of words
recalled after the delay. Six parallel forms are available.
Statistical analysis. The first step in generating the
overall composite cognitive score was to transform the raw
test score of each patient into a z score by using the mean
and standard deviation for that test in all the patients so that
the z score  (x –m)/; where x  the raw score for the
test, m  mean score of the test for the entire cohort, and
  the standard deviation of the test score for the entire
cohort. The z scores of each test were then summed and
divided by the total number of tests to calculate the pa- mient’s composite score (CS) so that CS   z  scores/n;
here n  total number of tests performed in the patient.
S was calculated at baseline and at follow-up. The change
n each patient’s standardized composite score from base-
ine to follow-up was used as the primary endpoint in this
tudy. The average change in composite score for patients
ndergoing CAS was then compared to that in patients
ndergoing CEA.
Since a group analysis combining the scores of all the
ests across multiple domains may not be sensitive to
hanges in one particular cognitive domain (ie, an improve-
ent in one domain may cancel out a decline in another
omain), a secondary analysis involved a comparison of
hange scores of each individual test.
ESULTS
Patient demographics. Forty-six patients with pri-
ary carotid artery stenosis agreed to participate in this
tudy and completed pre- and postprocedural cognitive
esting. Of these, 25 patients underwent CEA, and 21
nderwent CAS. Women comprised 36% of the cohort, the
ean preprocedural stenosis was 84%, and 56% were right-
ided lesions. These and other risk factor distributions were
ot significantly different between the two groups of pa-
ients (Table I). The CAS group had embolic protection in
ll cases, and the Abbott Acculink, Accunet system (Abbott
ark, IL) was utilized in all instances. All patients were
uccessfully revascularized without periprocedural stroke,
I, or deaths. Patients were followed for a mean of 5.2
onths (range, 4-6 months).
Cognitive outcomes. The composite and domain-
pecific cognitive outcomes are summarized in Table II.
he composite change score for the entire test battery
mproved in patients both after CEA and after CAS when
ompared to their baselines. However, the changes were
ot significantly different between the two groups (0.51
s 0.47; P  ns).
When individual test results were evaluated to assess the
utcome of individual cognitive functional domains
Fig 1), the scores improved for each test after CEA except
he Working Memory Index. This test measures working
able I. Demographic features of patients undergoing
AS and CEA for asymptomatic high-grade carotid artery
tenosis
CAS CEA
eature n  21 n  25 P
emale gender 38% 32% NS
ight-sided lesion 57% 56% NS
ercent stenosis (mean) 82% 88% NS
ypertension 42% 32% NS
oronary artery disease 62% 56% NS
ypercholesterolemia 67% 76% NS
iabetes 38% 28% NS
AS,Carotid artery stenting;CEA, carotid endarterectomy;NS,not significant.emory/concentration and was found to be decreased in
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(P  .001). The scores for each cognitive test improved
after CAS, except the Processing Speed Index, which de-
creased in 18 out of 21 patients. This test measures psy-
chomotor speed and was improved after CEA (P  .001).
DISCUSSION
In this nonrandomized study of neurologically asymp-
tomatic patients with high-grade carotid stenosis 70%,
carotid revascularization resulted in an overall improve-
ment in cognitive function. There were no differences in
the composite scores of six major cognitive domains be-
tween patients undergoing CEA versus CAS. When indi-
vidual tests were compared, CEA resulted in a reduction in
memory, while CAS patients showed reduced psychomotor
Table II. Standardized cognitive change scores (follow-up
asymptomatic high-grade carotid artery stenosis
Cognitive function test Domain
Pre-op
(SD)
Trail Making Test A
and B
Motor speed/coordination
and executive function
121 (22)
Processing Speed Index Psychomotor speed 107 (16)
Boston Naming Test Language (naming) 52 (8)
Working Memory
Index
Working memory/
concentration
100 (16)
Controlled Oral Word
Association Test
Verbal fluency 38 (9)
Hopkins Verbal
Learning Test
Learning/memory 7.9 (2.0)
Composite for all tests
NS, not significant; SD, standard deviation.
A positive change score indicates improvement in cognitive function after th
Fig 1. Change (follow-up vs baseline) in the cognitiv
individual test, in patients undergoing carotid artery ste
tomatic high-grade carotid artery stenosis. A positive ch
the procedure, a negative score indicates deterioration.speed. TCognitive function is the term used to describe how a
erson produces and controls behavioral and mental pro-
esses such as thinking, learning, remembering, problem
olving, and consciousness. Conversely, a neurologic deficit
s associated with a loss of localized sensory or motor
unction. The two types of deficits may occur alone or
oncurrently. There is clear evidence for the coexistence of
ognitive deficits in patients with stroke from carotid ste-
osis.19 However, a subset analysis of the Cardiovascular
ealth Study suggests that carotid stenosis may be a risk
actor for cognitive impairment even in the absence of
trokes.34 Of the 4,006 patients in that study, 32 were
dentified with asymptomatic carotid stenosis75%. These
atients, along with the rest of the cohort, were serially
ested with a modified mini-mental state examination.
aseline) in patients undergoing CAS and CEA for
Raw scores Change score
CEA CAS CEA
P
t-op
D) P
Pre-op
(SD)
Post-op
(SD) P n  21 n  25
(19) .44 138 (26) 129 (21) .04 0.63 0.74 NS
(16) .24 106 (13) 144 (14) .12 0.32 0.58 .001
(9) .11 56 (10) 63 (7) .06 0.59 0.66 NS
(12) .13 103 (15) 97 (12) .17 0.46 0.41 .001
(9) .07 39 (11) 46 (11) .09 0.69 0.61 NS
(1.9) .05 8.1 (1.7) 9.6 (2.1) .05 0.77 0.86 NS
0.47 0.51 NS
cedure, a negative score indicates deterioration.
res of a composite of all domains tested, and of each
(CAS) and carotid endarterectomy (CEA) for asymp-
score indicates improvement in cognitive function aftervs b
CAS
Pos
(S
120
102
57
108
44
9.4e sco
nting
angehere was a significant decline in cognitive function in 34%
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Volume 54, Number 3 Lal et al 695f the carotid stenosis patients over 5 years. Such a decline
as not observed in the remaining cohort. In our study,
arotid revascularization (by CEA or CAS) resulted in
mproved cognition. This indicates that revascularization
ay serve the dual function of preventing neurologic as
ell as cognitive decline in patients with carotid stenosis.
ognitive outcomes must be strongly considered as an
dditional outcome measure when future trials are de-
igned to evaluate the optimal treatment (revascularization
r pharmacologic) of neurologically asymptomatic pa-
ients.
While neurologic examinations focus on specific sen-
ory or motor deficits, cognitive assessments examine a set
f more-or-less independent functional domains.24 Most
ests are designed to test individual domains, but some may
xamine combined categories. All cognitive tests used in
ur study have standardized administration procedures
ith appropriate normative comparison groups. Guidelines
or the assessment of cognition in cardiac surgery7,24 and
edical treatment outcomes studies25 have been pub-
ished. However, a cognitive battery of tests specifically
ddressing the unique issues relating to carotid stenosis has
ot been devised. Our study reports on a cognitive test
attery that is comprehensive and responsive to the unique
ubset of carotid stenosis patients, while maintaining clin-
cal feasibility (takes approximately 50 minutes to com-
lete). The selected tests are sensitive to changes in six
ajor cognitive domains that have been reportedly
ffected in patients with vascular disease and carotid
tenosis.7-14,23-25
Crawley et al compared cognitive outcome in 20 pa-
ients undergoing carotid angioplasty without stenting and
6 patients undergoing CEA.10 At 6 weeks, five patients in
ach group had an equivalent decline in cognitive perfor-
ance. Another study based on the same cohort of patients
Carotid and Vertebral Artery Transluminal Angioplasty
tudy, CAVATAS)15 also demonstrated an equivalent de-
line in cognitive performance in both groups of patients.11
hese early studies highlighted the likelihood of cognitive
onsequences from carotid angioplasty. However, endo-
ascular carotid revascularization methodology has since
volved, and currently includes mandatory stenting with
mbolic protection in all patients treated for primary ath-
rosclerosis.35
The current standard CAS methodology was utilized
n a more recent study of 40 patients.12 Based on a
ini-mental state examination, the authors reported a
™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™
ig. 2. Representative diffusion-weighted magnetic resonance
mages of the brain before and after carotid artery stenting (CAS)
emonstrating a silent cortical microinfarct that did not manifest as
frank neurologic deficit on thorough neurological examination.
, Preprocedure diffusion-weighted coronal view. B, Preproce-
ure fluid-attenuated inversion-recovery (FLAIR) transverse im-
ge. C, Preprocedure diffusion-weighted transverse view. D, Dif-
usion-weighted transverse view obtained 24 hours postcarotid
tenting. Note new infarction (circled).
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CAS. The study received widespread reportage in the
media36; however, the cognitive battery utilized focused
primarily on left hemispheric cognitive functions and
patients with prior stroke (vs asymptomatic patients), or
patients with primary atherosclerosis (vs smooth, post-
CEA restenosis) were not separated out, thereby pre-
cluding any firm conclusions.
Our study compared CAS and CEA performed using
the current standard of care on a more consistent cohort
of asymptomatic patients with primary atherosclerosis.
The cognitive tests comprising our battery were selected
to assess multiple domains affected by right, left, or both
hemispheres, and to assess domains that have been con-
sistently reported to be affected in patients with vascular
disease and carotid artery stenosis. Our results are there-
fore likely to be reliable and applicable to current prac-
tice.
The notion that carotid artery disease can produce
cognitive impairment or a dementia state, was first pro-
posed by Dr Fisher in 1951, based on a necropsy case.37 He
proposed that restoration of blood supply could reverse the
condition. Improved cerebral blood flow has subsequently
been shown to translate into improved cognitive out-
come.38-40 Our results indicate that composite cognitive
function improves after revascularization regardless of the
method utilized (CAS or CEA) and are consistent with
Fisher’s original hypothesis.
Cerebral microinfarctions in the form of white matter
or cortical lesions correlate with poor cognition.41,42 In
experimental studies, injection of 50-mmicrospheres into
rat carotid arteries resulted in cerebral injury and reduced
attentional performance.43 Manipulation of the carotid
artery during surgical or endovascular revascularization
causes atheroembolization with consequent silent cerebral
microinfarction.44 Transcranial Doppler monitoring has
identified approximately 1000 microemboli during CAS
while CEA is associated with eight to 17 times fewer
microemboli.44,45 Consistent with the microembolization
rates, CAS results in cerebral microinfarctions more fre-
quently than CEA (54% vs 17%).46 One such microinfarct
in a post-CAS patient from our study is demonstrated in Fig
2. While the neurological complication rates between CAS
and CEA may not differ dramatically, these reports raise a
justifiable concern that silent microembolic cerebral injury
with consequent cognitive decline may occur more fre-
quently after CAS compared with CEA.
The fact that cognition, on average, was no different
between the two groups argues against a clinical signifi-
cance for the observed differences in microemboli and
microinfarctions between the two procedures. One study
has reported reduced microinfarction rates in patients un-
dergoing CAS with embolic protection versus unprotected
CAS (26% vs 36%).47 Therefore, it is possible that the
addition of anti-embolic devices may reduce cognitive in-
jury from CAS.
Despite the improvement in composite function, each
procedure adversely affected one unique cognitive domain. Ohis interesting observation argues in favor of distinct
njury patterns in each of the two procedures. Emboli
eleased during CEA tend to be larger in size despite being
ess numerous. It is possible that these stream preferentially
o areas critical to memory functions. Conversely, the more
umerous but smaller emboli associated with CAS may
istribute to the more globally controlled process of psy-
homotor speed.
IMITATIONS
This is a nonrandomized study with patient alloca-
ion to treatment groups made on the basis of physician–
atient preference and is therefore subject to selection
ias. In view of the limited cohort and lack of differences
n baseline characteristics, we did not perform a regres-
ion analysis. However, based on demographic compar-
sons, the two cohorts did not differ significantly, and
mportant conclusions can therefore be derived from the
esults. Importantly, baseline cognitive test results did
ot differ significantly between the two groups, implying
hat they started with a similar cognitive status. The
ohort studied is small, and the results are therefore
ubject to Type II error. However, in the absence of an
stablished cognitive testing battery and a comparison of
heir results and standard deviations in patients with CAS
ersus CEA, a power analysis with calculation of number
f patients required to be tested was not possible. The
esults of this study provide this information, and vali-
ate a carotid disease-specific cognitive test battery, for
acilitating future larger trials.
ONCLUSIONS
Individuals with cognitive deficits are at greater risk for
roblems with employment, activities of daily living, driv-
ng, social interactions, and family relationships. They also
ncur significantly higher costs related to personal assis-
ance.1,3 Reported and ongoing studies on carotid stenosis
ave not included cognitive outcome as an endpoint. Our
esults indicate a potentially beneficial effect on cognition
fter carotid revascularization and emphasize the need
or larger studies to confirm these findings. Our results
rgue in favor of incorporating cognitive testing in future
linical trials and in clinical practice related to carotid
rtery stenosis.
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